A Food Effect Study of LP-168 Tablets in Healthy Subjects

Clinical trial NCT05917964 · COMPLETED

Trial details

NCT number: NCT05917964
Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2023-06-21
Primary completion: 2023-08-21
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.